ST
GILD icon

Sentinel Trust’s Gilead Sciences GILD Stock Holding History

Sentinel Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-20,655
Closed -$1.56M – 111
2018
Q1 		$1.56M Sell
20,655
-42,315
-67% -$3.36M 0.33% 74
2017
Q4 		$4.51M Sell
62,970
-35,280
-36% -$2.68M 0.94% 32
2017
Q3 		$7.96M Sell
98,250
-22,660
-19% -$1.73M 1.34% 9
2017
Q2 		$8.56M Sell
120,910
-5,214
-4% -$347K 1.4% 8
2017
Q1 		$8.57M Buy
126,124
+33,045
+36% +$2.32M 1.36% 6
2016
Q4 		$6.67M Buy
93,079
+41,610
+81% +$3.09M 0.97% 10
2016
Q3 		$4.07M Buy
51,469
+44,925
+687% +$3.65M 0.59% 29
2016
Q2 		$546K Buy
+6,544
New +$581K 0.08% 94
2014
Q4 		– Sell
-2,247
Closed -$239K – 149
2014
Q3 		$239K Buy
+2,247
New +$220K 0.06% 132

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sentinel Trust's GILD Position: Q2 2018 in Review

Sentinel Trust sold out of Gilead Sciences (GILD) in Q2 2018, closing a stake of 20,655 shares — an estimated $1.56M sold.

Sentinel Trust first reported a position in GILD in Q3 2014 and held it in 9 quarters. The position peaked at $8.57M in Q1 2017. 1,522 funds tracked by Wall St. Rank hold GILD as of Q2 2018.

  • Sentinel Trust reported no remaining Gilead Sciences position as of Q2 2018 after selling out during the quarter.
  • Sentinel Trust sold 20,655 Gilead Sciences shares in Q2 2018, an estimated $1.56M.
  • Sentinel Trust first reported a position in Gilead Sciences in Q3 2014 and held it in 9 quarters.
  • Sentinel Trust's Gilead Sciences position peaked at $8.57M in Q1 2017.
  • 1,522 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2018.

Based on Sentinel Trust's 13F filing for Q2 2018, filed 15 Aug 2018.